93 related articles for article (PubMed ID: 21782150)
1. Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran in rat uterus.
Chandra V; Fatima I; Saxena R; Kitchlu S; Sharma S; Hussain MK; Hajela K; Bajpai P; Dwivedi A
Am J Obstet Gynecol; 2011 Oct; 205(4):362.e1-11. PubMed ID: 21782150
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumorigenic action of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran: evidence for involvement of GPR30/EGFR signaling pathway.
Chandra V; Fatima I; Saxena R; Hussain MK; Hajela K; Sankhwar P; Roy BG; Chandna S; Dwivedi A
Gynecol Oncol; 2013 May; 129(2):433-42. PubMed ID: 23402905
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of 2-(piperidinoethoxyphenyl)-3-(4-hydroxyphenyl)-2H-benzo(b)pyran (K-1) on human primary endometrial hyperplasial cells mediated via combined suppression of Wnt/β-catenin signaling and PI3K/Akt survival pathway.
Chandra V; Fatima I; Manohar M; Popli P; Sirohi VK; Hussain MK; Hajela K; Sankhwar P; Dwivedi A
Cell Death Dis; 2014 Aug; 5(8):e1380. PubMed ID: 25144715
[TBL] [Abstract][Full Text] [Related]
4. 2,3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human endometrial cancer cells.
Fatima I; Chandra V; Saxena R; Manohar M; Sanghani Y; Hajela K; Negi MP; Sankhwar PL; Jain SK; Dwivedi A
Mol Cell Endocrinol; 2012 Jan; 348(1):198-210. PubMed ID: 21878365
[TBL] [Abstract][Full Text] [Related]
5. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
6. Anti-implantation effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran, a potent antiestrogenic agent in rats.
Kharkwal G; Fatima I; Kitchlu S; Singh B; Hajela K; Dwivedi A
Fertil Steril; 2011 Mar; 95(4):1322-7. PubMed ID: 20674906
[TBL] [Abstract][Full Text] [Related]
7. Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent.
Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
Indian J Exp Biol; 1992 Nov; 30(11):968-71. PubMed ID: 1293041
[TBL] [Abstract][Full Text] [Related]
8. Modulation of AP-1 mediated estrogenic response by ormeloxifene in rat uterus.
Awasthi S; Daverey A; Dwivedi A
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):208-14. PubMed ID: 17553677
[TBL] [Abstract][Full Text] [Related]
9. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
[TBL] [Abstract][Full Text] [Related]
10. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
Davis AM; Ellersieck MR; Grimm KM; Rosenfeld CS
Mol Reprod Dev; 2006 Aug; 73(8):1034-44. PubMed ID: 16688783
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Akt expression and phosphorylation by 17beta-estradiol in the rat uterus during estrous cycle.
Dery MC; Leblanc V; Shooner C; Asselin E
Reprod Biol Endocrinol; 2003 Jun; 1():47. PubMed ID: 12816542
[TBL] [Abstract][Full Text] [Related]
12. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
[TBL] [Abstract][Full Text] [Related]
13. Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene.
Daverey A; Saxena R; Tewari S; Goel SK; Dwivedi A
J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):93-101. PubMed ID: 19460436
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
[TBL] [Abstract][Full Text] [Related]
15. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP
Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475
[TBL] [Abstract][Full Text] [Related]
16. SC79, the AKT Activator Protects Cerebral Ischemia in a Rat Model of Ischemia/Reperfusion Injury.
Luan Q; Pan L; He D; Gong X; Zhou H
Med Sci Monit; 2018 Aug; 24():5391-5397. PubMed ID: 30074018
[TBL] [Abstract][Full Text] [Related]
17. Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17beta-estradiol at estrus.
Leblanc V; Dery MC; Shooner C; Asselin E
Reprod Biol Endocrinol; 2003 Aug; 1():59. PubMed ID: 12967350
[TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator activated receptors-alpha and -gamma agonists on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.
Gunin AG; Bitter AD; Demakov AB; Vasilieva EN; Suslonova NV
J Endocrinol; 2004 Aug; 182(2):229-39. PubMed ID: 15283683
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
[TBL] [Abstract][Full Text] [Related]
20. Proliferation, mitosis orientation and morphogenetic changes in the uterus of mice following chronic treatment with both estrogen and glucocorticoid hormones.
Gunin AG; Mashin IN; Zakharov DA
J Endocrinol; 2001 Apr; 169(1):23-31. PubMed ID: 11250643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
